Todd Hulgan1, Asha R Kallianpur2, Yan Guo3,4, Jill S Barnholtz-Sloan5, Haley Gittleman5, Todd T Brown6, Ronald Ellis7, Scott Letendre7, Robert K Heaton7, David C Samuels3. 1. Vanderbilt University Medical Center, Nashville, TN. 2. Cleveland Clinic Foundation, Lerner Research Institute, Cleveland, OH. 3. Vanderbilt University School of Medicine, Nashville, TN. 4. Currently, University of New Mexico, Albuquerque, NM. 5. Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH. 6. Johns Hopkins University School of Medicine, Baltimore, MD. 7. University of California-San Diego, San Diego, CA.
Abstract
BACKGROUND: Mitochondrial DNA (mtDNA) copy number varies by cell type and energy demands. Blood mtDNA copy number has been associated with neurocognitive function in persons without HIV. Low mtDNA copy number may indicate disordered mtDNA replication; high copy number may reflect a response to mitochondrial dysfunction. We hypothesized that blood mtDNA copy number estimated from genome-wide genotyping data is related to neurocognitive impairment (NCI) in persons with HIV. METHODS: In the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study, peripheral blood mtDNA copy number was obtained from genome-wide genotyping data as a ratio of mtDNA single-nucleotide polymorphism probe intensities relative to nuclear DNA single-nucleotide polymorphisms. In a multivariable regression model, associations between mtDNA copy number and demographics, blood cell counts, and HIV disease and treatment characteristics were tested. Associations of mtDNA copy number with the global deficit score (GDS), GDS-defined NCI (GDS ≥ 0.5), and HIV-associated neurocognitive disorder (HAND) diagnosis were tested by logistic regression, adjusting for potential confounders. RESULTS: Among 1010 CHARTER participants, lower mtDNA copy number was associated with longer antiretroviral therapy duration (P < 0.001), but not with d-drug exposure (P = 0.85). mtDNA copy number was also associated with GDS (P = 0.007), GDS-defined NCI (P < 0.001), and HAND (P = 0.002). In all analyses, higher mtDNA copy number was associated with poorer cognitive performance. CONCLUSIONS: Higher mtDNA copy number estimated from peripheral blood genotyping was associated with worse neurocognitive performance in adults with HIV. These results suggest a connection between peripheral blood mtDNA and NCI, and may represent increased mtDNA replication in response to mitochondrial dysfunction.
BACKGROUND: Mitochondrial DNA (mtDNA) copy number varies by cell type and energy demands. Blood mtDNA copy number has been associated with neurocognitive function in persons without HIV. Low mtDNA copy number may indicate disordered mtDNA replication; high copy number may reflect a response to mitochondrial dysfunction. We hypothesized that blood mtDNA copy number estimated from genome-wide genotyping data is related to neurocognitive impairment (NCI) in persons with HIV. METHODS: In the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study, peripheral blood mtDNA copy number was obtained from genome-wide genotyping data as a ratio of mtDNA single-nucleotide polymorphism probe intensities relative to nuclear DNA single-nucleotide polymorphisms. In a multivariable regression model, associations between mtDNA copy number and demographics, blood cell counts, and HIV disease and treatment characteristics were tested. Associations of mtDNA copy number with the global deficit score (GDS), GDS-defined NCI (GDS ≥ 0.5), and HIV-associated neurocognitive disorder (HAND) diagnosis were tested by logistic regression, adjusting for potential confounders. RESULTS: Among 1010 CHARTER participants, lower mtDNA copy number was associated with longer antiretroviral therapy duration (P < 0.001), but not with d-drug exposure (P = 0.85). mtDNA copy number was also associated with GDS (P = 0.007), GDS-defined NCI (P < 0.001), and HAND (P = 0.002). In all analyses, higher mtDNA copy number was associated with poorer cognitive performance. CONCLUSIONS: Higher mtDNA copy number estimated from peripheral blood genotyping was associated with worse neurocognitive performance in adults with HIV. These results suggest a connection between peripheral blood mtDNA and NCI, and may represent increased mtDNA replication in response to mitochondrial dysfunction.
Authors: Marc van der Valk; Miriam Casula; Gerrit-Jan Weverlingz; Kees van Kuijk; Berthe van Eck-Smit; Hendrick-Jan Hulsebosch; Pythia Nieuwkerk; Arne van Eeden; Kees Brinkman; Joep Lange; Anthony de Ronde; Peter Reiss Journal: Antivir Ther Date: 2004-06
Authors: A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna Journal: Neurology Date: 2007-10-03 Impact factor: 9.910
Authors: Amy Fleischman; Stine Johnsen; David M Systrom; Mirko Hrovat; Christian T Farrar; Walter Frontera; Kathleen Fitch; Bijoy J Thomas; Martin Torriani; Hélène C F Côté; Steven K Grinspoon Journal: Am J Physiol Endocrinol Metab Date: 2007-02-06 Impact factor: 4.310
Authors: Marc A Norman; David J Moore; Michael Taylor; Donald Franklin; Lucette Cysique; Chris Ake; Deborah Lazarretto; Florin Vaida; Robert K Heaton Journal: J Clin Exp Neuropsychol Date: 2011-06-24 Impact factor: 2.475
Authors: Hélène C F Côté; Mariana Gerschenson; Ulrich A Walker; Oscar Miro; Gloria Garrabou; Emma Hammond; Joan Villarroya; Marta Giralt; Francesc Villarroya; Paola Cinque; Elena Garcia-Arumi; Antonio L Andreu; Marcello Pinti; Andrea Cossarizza Journal: Mitochondrion Date: 2011-02-22 Impact factor: 4.160
Authors: Lucette A Cysique; Donald Franklin; Ian Abramson; Ronald J Ellis; Scott Letendre; Ann Collier; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant; Robert K Heaton Journal: J Clin Exp Neuropsychol Date: 2011-03-07 Impact factor: 2.475
Authors: Steven Paul Woods; Julie D Rippeth; Alan B Frol; Joel K Levy; Elizabeth Ryan; Vicki M Soukup; Charles H Hinkin; Deborah Lazzaretto; Mariana Cherner; Thomas D Marcotte; Benjamin B Gelman; Susan Morgello; Elyse J Singer; Igor Grant; Robert K Heaton Journal: J Clin Exp Neuropsychol Date: 2004-09 Impact factor: 2.475
Authors: Dipesh Solanky; Jerel A Fields; Jennifer E Iudicello; Ronald J Ellis; Donald Franklin; David B Clifford; Benjamin B Gelman; Christina M Marra; Susan Morgello; Leah H Rubin; Igor Grant; Robert K Heaton; Scott L Letendre; Sanjay R Mehta Journal: J Neurovirol Date: 2022-02-14 Impact factor: 3.739
Authors: Cassandra C Soo; Meagan T Farrell; Stephen Tollman; Lisa Berkman; Almut Nebel; Michèle Ramsay Journal: Front Genet Date: 2021-10-14 Impact factor: 4.772